wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38807562-1C3C0828-1B30-4F93-961B-D6F6FBADD0F8
Q38807562-1C3C0828-1B30-4F93-961B-D6F6FBADD0F8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38807562-1C3C0828-1B30-4F93-961B-D6F6FBADD0F8
A retrospective analysis of 3954 patients in phase 2/3 trials of bortezomib for the treatment of multiple myeloma: towards providing a benchmark for the cardiac safety profile of proteasome inhibition in multiple myeloma.
P2860
Q38807562-1C3C0828-1B30-4F93-961B-D6F6FBADD0F8
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38807562-1C3C0828-1B30-4F93-961B-D6F6FBADD0F8
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
96a96c5d48f72e6e55613638e0a2d9a6021e70e5
P2860
U.s. Food and Drug Administration approval: carfilzomib for the treatment of multiple myeloma.